What is Bicara Therapeutics's expected dividend rate?

Bicara Therapeutics (BCAX) reported expected dividend rate of $0 in Q1 2026.

What does expected dividend rate mean?

The expected dividend rate represents the anticipated annual dividend yield used as an input in option pricing models. It accounts for the fact that option holders do not receive dividends, which impacts the fair value of the options granted. This metric provides insight into the company's dividend policy and its impact on equity-based compensation valuation.

Bicara Therapeutics BCAX Expected dividend rate

Expected dividend rate at other companies

SyscoSYY

2.8%+0.2pp

Boston BeerSAM

0%—

Quantum Computing Inc.QUBT

0%—

HCA HealthcareHCA

0.9%0.0pp

Charles River LaboratoriesCRL

0%—

ZymeworksZYME

0%—

Other financials

Income statement

See full

Operating income-$60.2M-44.2%

Net income-$56.2M-52.6%

EPS (diluted)-$0.93-36.8%

Balance sheet

See full

Cash & equivalents$323.5M-30.0%

Total debt$1.4M+144%

Total equity$514.0M+12.0%

Total assets$553.6M+15.8%

Cash flow

See full

Operating cash flow-$37.5M-33.5%

CapEx$60.0K—

Free cash flow-$37.6M-33.7%

Valuation

See full

Market cap$1.68B+81.4%

Returns & leverage

See full

Return on equity-32.3%—

Debt / equity0×0.0×

Current ratio13.9×-10.8×

Where this comes from

Reported directly by Bicara Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend.

The official record: Bicara Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bicara Therapeutics's expected dividend rate.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bicara Therapeutics's expected dividend rate?: Bicara Therapeutics (BCAX) reported expected dividend rate of $0 in Q1 2026.
What does expected dividend rate mean?: The expected dividend rate represents the anticipated annual dividend yield used as an input in option pricing models. It accounts for the fact that option holders do not receive dividends, which impacts the fair value of the options granted. This metric provides insight into the company's dividend policy and its impact on equity-based compensation valuation.